UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


SCHEDULE 13G


Amendment No. 1


Under the Securities and Exchange Act of 1934


Zivo Bioscience, Inc.

(f/k/a Health Enhancement Products, Inc.)

(Name of Issuer)

 

Common Stock, $.001 par value

(Title of Class of Securities)

 

98978N 101

(CUSIP Number)

 

December 31, 2014

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this is filed:


      .Rule 13d-1(b)

  X .Rule 13d-1(c)

      .Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).





CUSIP NO. 98978N 101

Page    2     of    5    Pages


1

NAMES OF REPORTING PERSONS

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)

 

 

 

Christopher D. Maggiore

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

 

 (a)      .

 

 (b)      .

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

 

U.S.A.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5

SOLE VOTING POWER

 

 

 

21,926,129 shares

6

SHARED VOTING POWER

 

 

 

8,319,955 shares

7

SOLE DISPOSITIVE POWER

 

 

 

21,926,129 shares

8

SHARED DISPOSITIVE POWER

 

 

 

8,319,955  shares

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

 

30,246,084

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

 

 

N/A

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

 

 

22.0%

12

TYPE OF REPORTING PERSON

 

 

 

IN




2




Item 1(a)


The name of the issuer is Zivo Bioscience, Inc. (f/k/a Health Enhancement Products, Inc.)


Item 1(b)


The address of the Issuer's principal executive offices is: 2804 Orchard Lake Rd., Keego Harbor, Michigan 48320


Tel. Number:  (248) 452 9866


Item 2(a)


The name of reporting person is:  Christopher D. Maggiore


Item 2(b)


The residence address of the Reporting Person is: 4788 Nobles Pond Dr. NW, Canton, OH 44718


Item 2(c)


The citizenship of the reporting Person is:  USA


Item 2(d)


The title of the class of securities is:  Common Stock, $0.001 par value


Item 2(e)


The CUSIP Number of the securities is:  98978N 101


Item 3


This statement is not filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c).


Item 4


Ownership:


The Reporting Person is the beneficial owner of 30,246,084 shares, representing 22.0% of the class of securities.


The Reporting Person has:


(i)

sole power to vote or to direct the vote of:  21,926,129 shares

(ii)

shared power to vote or to direct the vote of:   8,319,955 shares

(iii)

sole power to dispose or to direct the disposition of: 21,926,129 shares

(iv)

shared power to dispose or to direct the disposition of:   8,319,955 shares


Item 5


Ownership of Five Percent or Less of Class:  Not Applicable


Item 6


Ownership of More than Five Percent on Behalf of another Person:  Not Applicable



3




Item 7


Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company:  Not Applicable


Item 8


Identification and Classification of Members of the Group:  Not Applicable


Item 9


Notice of Dissolution of Group:  Not Applicable


Item 10


Certification:


By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.



4




SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


February 17, 2015

Date


/s/ Christopher D. Maggiore

Signature


Christopher D. Maggiore

Name



5


Zivo Bioscience (QB) (USOTC:ZIVO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Zivo Bioscience (QB) Charts.
Zivo Bioscience (QB) (USOTC:ZIVO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Zivo Bioscience (QB) Charts.